Comment on AbbVie to Buy Pharmacyclics to Expand In Cancer Therapy - Bloomberg

AbbVie to Buy Pharmacyclics to Expand In Cancer Therapy - Bloomberg

Chicago Sun-TimesAbbVie to Buy Pharmacyclics to Expand In Cancer TherapyBloomberg(Bloomberg) -- AbbVie Inc. agreed to buy Pharmacyclics Inc. in a deal that gives it control of a blockbuster blood cancer therapy and values the smaller drugmaker at $21 billion. Under the terms of the transaction, AbbVie will pay $261.25 per share comprised ...AbbVie to buy cancer drug maker Pharmacyclics in $21 billion dealReutersAbbvie To Pay $21 Billion For Cancer Biotech PharmacyclicsForbesAbbVie to Buy Pharmacyclics in $21 Billion Deal -- UpdateNasdaqChicago Sun-Times -KDALall 11 news articles »

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News